"Dextromethorphan/Quinidine for the Pseudobulbar Affect in Neurological" by Magnolia Livingston
 

Honors Theses

Date of Award

Spring 5-14-2023

Document Type

Undergraduate Thesis

Department

Chemistry and Biochemistry

First Advisor

Toshikazu Ikuta

Second Advisor

Laura Dixon

Third Advisor

Todd Smitherman

Relational Format

dissertation/thesis

Abstract

AVP-923, commonly known as Nuedexta or Zenvia, is a drug that has recently been suggested as a potential treatment for Pseudobulbar Affect in patients affected by different neurological disorders and injuries. Studies have been done to examine the effectiveness of AVP-923 on PBA, but the results of these studies don’t seem to be comparable. The goal of this meta-analysis is to assess the efficacy and safety of AVP-923. 781 individuals from six trials were included in the analysis. The analysis's findings revealed that AVP-923 considerably lowered the Center for Neurological Study Lability Scale (CNS-LS) scores and the frequency and severity of PBA episodes in these individuals. With mild to moderate side effects observed, the medication was also found to be safe and well-tolerated. The findings of this meta-analysis provide important clinical implications for the management of PBA symptoms in this patient population.

Accessibility Status

Searchable text

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.